Skip to main navigation Skip to search Skip to main content

Erratum: A Novel Deletion Mutation in pmrB Contributes to Concurrent Colistin Resistance in Carbapenem- Resistant Escherichia coli Sequence Type 405 of Clinical Origin (Antimicrobial Agents and Chemotherapy (2020) 64:6 (e00220-20) DOI: 10.1128/AAC.00220-20)

  • Ching Hsun Wang
  • , L. Kristopher Siu
  • , Feng Yee Chang
  • , Yu Kuo Tsai
  • , Yi Tsung Lin
  • , Sheng Kang Chiu
  • , Li Yueh Huang
  • , Jung Chung Lin*
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Volume 64, no. 6, e00220-20, 2020, https://doi.org/10.1128/AAC.00220-20. An additional affiliation should be included for the first author. This has been added as affiliation "d"above.

Original languageEnglish
Article numbere01374-21
JournalAntimicrobial Agents and Chemotherapy
Volume65
Issue number9
DOIs
StatePublished - Sep 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum: A Novel Deletion Mutation in pmrB Contributes to Concurrent Colistin Resistance in Carbapenem- Resistant Escherichia coli Sequence Type 405 of Clinical Origin (Antimicrobial Agents and Chemotherapy (2020) 64:6 (e00220-20) DOI: 10.1128/AAC.00220-20)'. Together they form a unique fingerprint.

Cite this